Steven Burrill Insider Profile
4 Followers
Steven Burrill, Director at Gyre Therapeutics, holds 4.33K shares in Gyre Therapeutics (Ticker: GYRE), holds 40.00K shares in Assertio Therapeutics (Ticker: ASRT). Most recently, Steven Burrill Bought ― shares of Gyre Therapeutics on Aug 01, 2012 for an estimated value of $303.31.
Steven Burrill's Trading History
| GYREGyre Therapeutics | Aug 01, 2012 | Director | Informative Buy | 303.31 | $18.68K | |
| ASRTAssertio Therapeutics | May 13, 2011 | ― | Informative Sell | 1.28M | $940.00K |
You May Also Like
Steven Burrill insider profile FAQ
What is the percentage of profitable transactions made by Steven Burrill?
The percentage of profitable transactions made by Steven Burrill is 67%.
What is the average return per transaction made by Steven Burrill?
The average return per transaction made by Steven Burrill is 32.90%.
What stocks does Steven Burrill hold?
Steven Burrill holds: GYRE, ASRT stocks.
What was Steven Burrill’s latest transaction?
Steven Burrill’s latest transaction was an Informative Buy of $303.31.
What was Steven Burrill's most profitable transaction?
Steven Burrill’s most profitable transaction was an Informative Sell of GYRE stock on May 12, 2011. The return on the trade was 80.70%.
What is Steven Burrill's role in Gyre Therapeutics?
Steven Burrill's role in Gyre Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
